...
首页> 外文期刊>Brain research >Angiotensin II and CRF receptors in the central nucleus of the amygdala mediate hemodynamic response variability to cocaine in conscious rats.
【24h】

Angiotensin II and CRF receptors in the central nucleus of the amygdala mediate hemodynamic response variability to cocaine in conscious rats.

机译:杏仁核中央核中的血管紧张素II和CRF受体介导清醒大鼠可卡因的血流动力学响应变异性。

获取原文
获取原文并翻译 | 示例

摘要

Stress or cocaine evokes either a large increase in systemic vascular resistance (SVR) or a smaller increase in SVR accompanied by an increase in cardiac output (designated vascular and mixed responders, respectively) in Sprague-Dawley rats. We hypothesized that the central nucleus of the amygdala (CeA) mediates this variability. Conscious, freely-moving rats, instrumented for measurement of arterial pressure and cardiac output and for drug delivery into the CeA, were given cocaine (5 mg/kg, iv, 4-6 times) and characterized as vascular (n=15) or mixed responders (n=10). Subsequently, we administered cocaine after bilateral microinjections (100 nl) of saline or selective agents in the CeA. Muscimol (80 pmol), a GABA(A) agonist, or losartan (43.4 pmol), an AT(1) receptor antagonist, attenuated the cocaine-induced increase in SVR in vascular responders, selectively, such that vascular responders were no longer different from mixed responders. The corticotropin releasing factor (CRF) antagonist, alpha-helical CRF(9-41) (15.7 pmol), abolished the difference between cardiac output and SVR in mixed and vascular responders. We conclude that greater increases in SVR observed in vascular responders are dependent on AT(1) receptor activation and, to a lesser extent on CRF receptors. Therefore, AT(1) and CRF receptors in the CeA contribute to hemodynamic response variability to intravenous cocaine.
机译:在Sprague-Dawley大鼠中,压力或可卡因引起全身血管阻力(SVR)的大幅增加或SVR的较小增加,并伴随心输出量增加(分别称为血管反应和混合反应)。我们假设杏仁核的中央核(CeA)介导了这种变异性。对有意识的自由活动大鼠进行可卡因(5 mg / kg,静脉内,4-6次)的测量,以测量动脉压和心输出量并将药物输送到CeA中,并将其表征为血管(n = 15)或混合响应者(n = 10)。随后,我们在CeA中双侧注射(100 nl)盐水或选择剂后给予可卡因。 Muscimol(80 pmol),一种GABA(A)激动剂,或losartan(43.4 pmol),一种AT(1)受体拮抗剂,选择性地减弱了可卡因诱导的SVR在血管反应者中的升高,从而使血管反应者不再不同来自不同的响应者。促肾上腺皮质激素释放因子(CRF)拮抗剂α-螺旋CRF(9-41)(15.7 pmol)消除了混合反应者和血管反应者的心输出量和SVR之间的差异。我们得出的结论是,在血管反应者中观察到的SVR的较大增加取决于AT(1)受体的激活,而在较小程度上取决于CRF受体。因此,CeA中的AT(1)和CRF受体有助于对静脉注射可卡因的血液动力学响应变异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号